Rhodopsin, the visual pigment mediating vision under dim light, is composed of the apoprotein opsin and the chromophore ligand 11-cis-retinal. A P23H mutation in the opsin gene is one of the most prevalent causes of the human blinding disease, autosomal dominant retinitis pigmentosa. Although P23H cultured cell and transgenic animal models have been developed, there remains controversy over whether they fully mimic the human phenotype; and the exact mechanism by which this mutation leads to photoreceptor cell degeneration remains unknown. By generating P23H opsin knock-in mice, we found that the P23H protein was inadequately glycosylated with levels 1-10% that of wild type opsin. Moreover, the P23H protein failed to accumulate in rod photoreceptor cell endoplasmic reticulum but instead disrupted rod photoreceptor disks. Genetically engineered P23H mice lacking the chromophore showed accelerated photoreceptor cell degeneration. These results indicate that most synthesized P23H protein is degraded, and its retinal cytotoxicity is enhanced by lack of the 11-cisretinal chromophore during rod outer segment development.Greater understanding of a genetically heterogeneous group of retinal disorders is now possible due to the results of studies that have revealed their causative genes. Many genetic loci can cause such retinopathies (RetNet) (1). Mutations in phototransduction genes, including those in opsin genes (2), constitute one of the major known causes of inherited blinding diseases (3). Among them, retinitis pigmentosa (RP) 2 refers to a group that displays genetic heterogeneity and a range of clinical phenotypes (4). RP manifested predominantly by death of rod photoreceptor cells is a progressive disease characterized by night blindness that progresses to loss of peripheral vision and eventually all useful vision over decades (5). Of more than 100 mutant opsins associated with autosomal dominant RP (adRP), the most frequent mutation is P23H (6), accounting for ϳ10% of human cases (7,8).In vitro studies have shown that the P23H opsin associated with adRP is misfolded and retained in the ER (9 -12). Consequently, this protein is not transported to the cell membrane (12) but instead was degraded by the ubiquitin-proteosome system (13). Co-expression of adRP-linked opsin folding-deficient mutants and wild type (WT) opsin resulted in enhanced proteosome-mediated degradation and steady-state ubiquitination of both mutant and WT opsin in an experimental cell line (14). These results imply that in vivo, a misfolded monomer of P23H opsin can also induce co-aggregation with WT rhodopsin preventing rod outer segment (ROS) formation. This dominant negative effect on ROS formation has been considered as the underlying reason for the adRP inheritance of P23H in humans.The retinal structure in heterozygous transgenic mice and rats expressing the P23H opsin partially mimics that of adRP in humans carrying this mutation (15)(16)(17)(18)(19). Mislocalization of the P23H opsin in the retina also has been reported in transgenic ani...

Guanylate cyclase-activating proteins (GCAPs) are Ca(2+)-binding proteins myristoylated at the N terminus that regulate guanylate cyclases in photoreceptor cells and belong to the family of neuronal calcium sensors (NCS). Many NCS proteins display a recoverin-like "calcium-myristoyl switch" whereby the myristoyl group, buried inside the protein in the Ca(2+)-free state, becomes fully exposed upon Ca(2+) binding. Here we present a 2.0 A resolution crystal structure of myristoylated GCAP1 with Ca(2+) bound. The acyl group is buried inside Ca(2+)-bound GCAP1. This is in sharp contrast to Ca(2+)-bound recoverin, where the myristoyl group is solvent exposed. Furthermore, we provide direct evidence that the acyl group in GCAP1 remains buried in the Ca(2+)-free state and does not undergo switching. A pronounced kink in the C-terminal helix and the presence of the myristoyl group allow clustering of sequence elements crucial for GCAP1 activity.

In vertebrate retinal photoreceptors, the absorption of light by rhodopsin leads to photoisomerization of 11-cis-retinal to its all-trans isomer. To sustain vision, a metabolic system evolved that recycles all-trans-retinal back to 11-cis-retinal. The importance of this visual (retinoid) cycle is underscored by the fact that mutations in genes encoding visual cycle components induce a wide spectrum of diseases characterized by abnormal levels of specific retinoid cycle intermediates. In addition, intense illumination can produce retinoid cycle by-products that are toxic to the retina. Thus, inhibition of the retinoid cycle has therapeutic potential in physiological and pathological states. Four classes of inhibitors that include retinoid and nonretinoid compounds have been identified. We investigated the modes of action of these inhibitors by using purified visual cycle components and in vivo systems. We report that retinylamine was the most potent and specific inhibitor of the retinoid cycle among the tested compounds and that it targets the retinoid isomerase, RPE65. Hydrophobic primary amines like farnesylamine also showed inhibitory potency but a short duration of action, probably due to rapid metabolism. These compounds also are reactive nucleophiles with potentially high cellular toxicity. We also evaluated the role of a specific proteinmediated mechanism on retinoid cycle inhibitor uptake by the eye. Our results show that retinylamine is transported to and taken up by the eye by retinol-binding protein-independent and retinoic acid-responsive gene product 6-independent mechanisms. Finally, we provide evidence for a crucial role of lecithin: retinol acyltransferase activity in mediating tissue specific absorption and long lasting therapeutic effects of retinoid-based visual cycle inhibitors.In vertebrate photoreceptor cells, absorbance of light by the visual chromophore, 11-cis-retinal, coupled to rhodopsin leads to its photoisomerization to all-trans-retinal and initiation of the phototransduction signal cascade (reviewed in Ref. 1). To ensure constant vision, 11-cis-retinal is efficiently regenerated by a complex sequence of enzymatic reactions called the visual or retinoid cycle (reviewed in Refs. 2-4). This pathway is located in both retinal pigment epithelium (RPE) 3 and photoreceptor cells. The key enzymatic step of visual chromophore regeneration is the isomerization of all-trans-retinyl palmitate and other esters to 11-cis-retinol in a reaction catalyzed by RPE65 (5-7).The importance of the retinoid cycle for maintaining vision is documented by the number and variety of diseases caused by mutations in genes encoding proteins involved in this process (2). Three main strategies have been developed to treat these diseases. The first uses virally mediated transfer gene technology to replace the defective gene. This approach has successfully rescued vision in mouse and dog models of Leber congenital amaurosis and retinitis pigmentosa (8 -13). The second approach involving pharmacological supplementation...

Extended Data Fig. 2 RagAB binds a wide range of oligopeptides EDFig2.tiff a-c, LC-MS/MS analysis of peptides bound to RagAB W83 KRAB, showing length distribution (a), total charge (b) and pI (c). d-f, Analysis of peptides bound to RagAB W83 wild-type, showing length distribution (d), total charge (e) and pI (f). For charge calculations, the pH was assumed to be 7.0 and contributions of any His residues were ignored. g, Amino acid frequency of RagAB-bound peptides (KRAB and wild-type combined; black) vs. the amino acid composition in the P. gingivalis proteome (gray), showing a substantial enrichment of Ala, Glu, Lys, Thr and Val. By contrast, aromatics (Phe, Trp) and bulky hydrophobics (Leu) appear to be underrepresented. The peptides bound to RagAB from W83 KRAB vary in length from 7 to 29 residues, with a broad maximum of around 13 residues that fits well with the peptide density observed in the structures. Assuming equal abundance of each detected peptide, there is a slight preference for neutral to slightly acidic peptides, and the pI distribution has a bimodal shape, with maxima for acidic and slightly basic peptides. Analysis of the smaller RagAB-bound peptide set from wild-type W83 (d-f) yields a slightly wider size range from 5-36 residues, but overall there are no dramatic differences in the collective length, net charge and pI of the RagAB-bound peptide populations from W83 KRAB and wild-type strains. Extended Data Fig. 3 Molecular dynamics simulations of RagAB show lid opening EDFig3.tiff a, C α-rmsd values of RagB lids in apo-RagAB (red) and peptide-bound RagAB (green) with reference to the starting crystal structure in the closed conformation. The C α-rmsd values of the RagB lids in RagA 2 B 2 are shown in blue with reference to the OO EM state. Each point indicates an average of 50 ns simulation trajectory. b, Comparison of the RagA 2 B 2 open conformation from EM (magenta) Data description i.e.

The GUCA1A gene encodes a guanylate cyclase-activating protein (GCAP1) that is involved in regulation of phototransduction in the vertebrate retina. We discovered a novel C312A transversion in exon 2 of the human GUCA1A gene, replacing Asn-104 (N104) in GCAP1 with Lys (K), in two affected members of a family with dominant cone dystrophy. The mutation N104K is located in the third EF hand motif (EF3) shown previously to be instrumental in converting Ca2+-free GCAP1 to a GC inhibitor in the Ca2+-bound form. In one patient, rod ERGs were fairly stable over a 12-year-period whereas 30 Hz flicker ERG and single-flash cone ERGs declined. In both patients, double flash ERGs showed that rod recovery from an intense test flash was significantly delayed. The EC50 for GC stimulation shifted from ~250 nM in wild-type GCAP1 to ~800 nM in the GCAP1(N104K) mutant suggesting inability of the mutant to assume an inactive form under physiological conditions. The replacement of N104 by K in GCAP1 is the first naturally occurring mutation identified in the EF3 loop. The rod recovery delays observed in double-flash ERG of affected patients suggest a novel dominant-negative effect that slows GC stimulation.